Given that gastric tumors (especially malignant tumor types) have higher copper and lactate concentrations than normal tissues, treatment with copper ionophores to bind copper ions and SIRT2-specific inhibitor may serve as a feasible and available strategy for gastric cancer therapy. Here, SIRT2 is linked to gastric cancer.